I. Shui, A. Mondul, and S. Lindstrom, Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium, Cancer, vol.98, issue.12
DOI : 10.1002/cncr.29320

D. Feldman, A. Krishnan, and S. Swami, The role of vitamin D in reducing cancer risk and progression, Nature Reviews Cancer, vol.29, issue.5, pp.342-357, 2014.
DOI : 10.1158/1055-9965.EPI-13-0007-T

T. Chen, T. Sakaki, and K. Yamamoto, The roles of cytochrome P450 enzymes in prostate cancer development and treatment, Anticancer Res, vol.32, pp.291-298, 2012.

R. Heaney, L. Armas, and J. Shary, 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions, Am. J. Clin. Nutr, vol.87, pp.1738-1742, 2008.

C. Garland, C. French, and L. Baggerly, Vitamin D supplement doses and serum 25- hydroxyvitamin D in the range associated with cancer prevention, Anticancer Res, vol.31, pp.607-611, 2011.

M. El-atifi, M. Dreyfus, F. Berger, and D. Wion, Expression of CYP2R1 and VDR in human brain pericytes, NeuroReport, vol.26, issue.5, pp.245-248, 2015.
DOI : 10.1097/WNR.0000000000000328

URL : https://hal.archives-ouvertes.fr/inserm-01342467